Abstract

Cystic fibrosis (CF) is a multisystemic, autosomal recessive disorder caused by mutations in the CFTR (cystic fibrosis transmembrane conductance regulator) gene, with the majority of morbidity and mortality extending from lung disease. Single-cell RNA sequencing (scRNA-seq) has been leveraged in the lun and elsewhere in the body to articulate discrete cell populations, describing cell types, states, and lineages as well as their roles in health and disease. In this translational review, we provide an overview of the current applications of scRNA-seq to the study of the normal and CF lungs, allowing the beginning of a new cellular and molecular narrative of CF lung disease, and we highlight some of the future opportunities to further leverage scRNA-seq and complementary single-cell technologies in the study of CF as we bridge from scientific understanding to clinical application.

Original languageEnglish
Pages (from-to)131-139
Number of pages9
JournalAmerican Journal of Respiratory Cell and Molecular Biology
Volume68
Issue number2
DOIs
StatePublished - 2023

Keywords

  • CFTR
  • cystic fibrosis
  • single-cell RNA sequencing
  • single-cell spatial transcriptomics
  • single-cell technologies

Fingerprint

Dive into the research topics of 'Single-Cell RNA Sequencing Reveals New Basic and Translational Insights in the Cystic Fibrosis Lung'. Together they form a unique fingerprint.

Cite this